Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4660-4665
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4660
Table 1 Relative miR-20a and let-7a levels
GroupAge (yr)miR-20alet-7a
ESCC patients60.48 ± 8.402.09 ± 1.390.53 ± 0.43
Healthy controls61.72 ± 6.931.12 ± 0.681.13 ± 0.58
P-value0.4310.0000.000
Table 2 Correlation between miR-20a and let-7a levels and clinicopathologic features in patients with esophageal squamous cell carcinoma
CharacteristicsnFold change1
miR-20alet-7a
Gender
Male461.61 (0.95-2.82)0.33 (0.22-0.53)
Female241.63 (1.33-2.93)0.45 (0.29-0.89)
P-value0.4810.107
Age (yr)
≤ 60371.62 (1.24-2.89)0.39 (0.23-0.79)
> 60331.62 (1.06-2.82)0.35 (0.24-0.64)
P-value0.4630.900
Diameter of tumor
< 4 cm361.51 (0.99-2.47)0.40 (0.23-0.79)
≥ 4 cm342.10 (1.33-3.08)0.36 (0.24-0.62)
P-value0.0770.961
TNM stage
I/II491.52 (0.95-2.80)0.42 (0.28-0.88)
III/IV212.04 (1.40-3.40)0.24 (0.19-0.39)
P-value0.1180.009
Distant metastasis
M0611.62 (1.10-2.82)0.39 (0.24-0.79)
M191.64 (1.21-4.45)0.35 (0.12-0.44)
P-value0.3000.174
Histologic grade
Well differentiated251.50 (1.10-2.41)0.45 (0.25-0.59)
Moderately differentiated281.76 (1.04-2.82)0.33 (0.26-0.97)
Poorly differentiated171.75 (1.21-3.29)0.30 (0.22-0.62)
P-value0.6320.849